Association between serum insulin levels and heart failure-related parameters in patients with type 2 diabetes and heart failure treated with canagliflozin: a post-hoc analysis of the randomized CANDLE trial

被引：0
|
作者：
Atsushi Tanaka
Takumi Imai
Michio Shimabukuro
Isao Taguchi
Akira Sezai
Shigeru Toyoda
Hirotaka Watada
Junya Ako
Koichi Node
机构：
[1] Saga University,Department of Cardiovascular Medicine
[2] Osaka Metropolitan University,Department of Medical Statistics, Graduate School of Medicine
[3] Fukushima Medical University,Department of Diabetes, Endocrinology, and Metabolism
[4] Dokkyo Medical University Saitama Medical Center,Department of Cardiology
[5] Nihon University School of Medicine,Department of Cardiovascular Surgery
[6] Dokkyo Medical University School of Medicine,Department of Cardiovascular Medicine
[7] Juntendo University Graduate School of Medicine,Department of Metabolism & Endocrinology
[8] Kitasato University School of Medicine,Department of Cardiovascular Medicine
来源：
Cardiovascular Diabetology | / 21卷
关键词：
Type 2 diabetes; Chronic heart failure; Canagliflozin; Glimepiride; Insulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Association between serum insulin levels and heart failure-related parameters in patients with type 2 diabetes and heart failure treated with canagliflozin: a post-hoc analysis of the randomized CANDLE trial
    Tanaka, Atsushi
    Imai, Takumi
    Shimabukuro, Michio
    Taguchi, Isao
    Sezai, Akira
    Toyoda, Shigeru
    Watada, Hirotaka
    Ako, Junya
    Node, Koichi
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [2] ASSOCIATION BETWEEN SERUM INSULIN LEVELS AND HEART FAILURE-RELATED PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE
    Tanaka, Atsushi
    Node, Koichi
    JOURNAL OF HYPERTENSION, 2023, 41 : E381 - E382
  • [3] Effects of canagliflozin in patients with type 2 diabetes and chronic heart failure: a randomized trial (CANDLE)
    Tanaka, A.
    Hisauchi, I
    Taguchi, I
    Sezai, A.
    Toyoda, S.
    Tomoyamas, H.
    Setae, M.
    Ueda, S.
    Oyama, J.
    Kitakaze, M.
    Murohara, T.
    Node, K.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1151 - 1151
  • [4] Effects of canagliflozin in patients with type 2 diabetes and chronic heart failure: a randomized trial (CANDLE)
    Tanaka, Atsushi
    Hisauchi, Itaru
    Taguchi, Isao
    Sezai, Akira
    Toyoda, Shigeru
    Tomiyama, Hirofumi
    Sata, Masataka
    Ueda, Shinichiro
    Oyama, Jun-ichi
    Kitakaze, Masafumi
    Murohara, Toyoaki
    Node, Koichi
    ESC HEART FAILURE, 2020, 7 (04): : 1585 - 1594
  • [5] Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial
    Yamaguchi, Satoshi
    Shimabukuro, Michio
    Tanaka, Atsushi
    Imai, Takumi
    Hiramitsu, Shinya
    Takahashi, Naohiko
    Kadokami, Toshiaki
    Ajioka, Masayoshi
    Suzuki, Makoto
    Node, Koichi
    DIABETES OBESITY & METABOLISM, 2023, 25 (02): : 354 - 364
  • [6] RENOPROTECTIVE EFFECTS OF CANAGLIFLOZIN VIA LESSENING HYPERINSULINEMIA IN DIABETIC PATIENTS WITH HEART FAILURE: A POST-HOC ANALYSIS OF THE CANDLE TRIAL
    Yamaguchi, Satoshi
    Shimabukuro, Michio
    Tanaka, Atsushi
    Node, Koichi
    JOURNAL OF HYPERTENSION, 2023, 41 : E137 - E137
  • [7] Effects of Canagliflozin in Patients With Type 2 Diabetes and Chronic Heart Failure: A Randomized Clinical Trial (CANDLE)
    Tanaka, Atsushi
    Hisauchi, Itaru
    Taguchi, Isao
    Sezai, Akira
    Toyoda, Shigeru
    Sata, Masataka
    Ueda, Shinichiro
    Oyama, Jun-ichi
    Kitakaze, Masafumi
    Murohara, Toyoaki
    Node, Koichi
    CIRCULATION, 2019, 140
  • [8] Effect of canagliflozin on white blood cell counts in patients with type 2 diabetes and heart failure: A subanalysis of the randomized CANDLE trial
    Tanaka, Atsushi
    Imai, Takumi
    Shimabukuro, Michio
    Nakamura, Ikuko
    Matsunaga, Kazuo
    Ozaki, Yukio
    Minamino, Tohru
    Sata, Masataka
    Node, Koichi
    JOURNAL OF DIABETES INVESTIGATION, 2022, : 1990 - 1999
  • [9] Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the REWIND randomized trial
    Branch, Kelley
    Dagenais, G.
    Avezum, A.
    Basile, J.
    Conget, I.
    Cushman, W. C.
    Jansky, P.
    Lakshmanan, M.
    Lanas, F.
    Leitner, L. A.
    Pais, P.
    Pogosova, N.
    Raubenheimer, P. J.
    Gerstein, H.
    Probstfield, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 158 - 159
  • [10] Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial
    Branch, Kelley R. H.
    Dagenais, Gilles R.
    Avezum, Alvaro
    Basile, Jan
    Conget, Ignacio
    Cushman, William C.
    Jansky, Petr
    Lakshmanan, Mark
    Lanas, Fernando
    Leiter, Lawrence A.
    Pais, Prem
    Pogosova, Nana
    Raubenheimer, Peter J.
    Ryden, Lars
    Shaw, Jonathan E.
    Sheu, Wayne H-H
    Temelkova-Kurktschiev, Theodora
    Bethel, M. Angelyn
    Gerstein, Hertzel C.
    Chinthanie, Ramasundarahettige
    Probstfield, Jeffrey L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1805 - 1812
12345